Treatment of Skin eruptions by Unani medicine Habb e Musaffi Khoon
- Conditions
- Rash and other nonspecific skin eruption,
- Registration Number
- CTRI/2019/03/018087
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
This study is designed as a multicentric open trial in patients with **Busoor-e-Jild (Skin Eruptions).** After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients will be treated with Unani pharmacopoeial formulation *Hab-e-Musaffi* *Khoon* four pills daily with water for two weeks. The patients will be assessed at every week. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be two weeks. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.
**Composition of *Hab-e-Musaffi Khoon***
| | | | |
| --- | --- | --- | --- |
|**S. No.**
**Ingredients**
**Botanical/Scientific name**
**Quantity**
|
Berg Bakayin
*Melia azedarach* Linn.
10 gm.
|
Berg Neem
*Azadirachta indica* A. Juss.
10 gm.
|
Berg Hina
*Lawsonia alba*
30 gm.
|
Burada Sandal Surkh
*Pterocarpus santalinus* Linn. f.
30 gm.
|
Barhamdandi
*Tricholepis glaberrima* DC.
30 gm.
|
Post Haleela Zard
*Terminalia chebula* Retz.
30 gm.
|
Chaksu
*Cassia absus* Linn.
30 gm.
|
Rasaut (extract)
*Berberis aristata* DC.
30 gm.
|
Zeera Safaid
*Cuminum cyminum* Linn.
10 gm.
|
Sarphoka
*Tephrosia purpurea* (L.) Pers.
30 gm.
|
Shahtra
*Fumaria officinalis* Linn.
30 gm.
|
Filfil Siyah
*Piper nigrum* Linn.
10 gm.
|
Kishneez Khushk
*Coriandrum sativum* Linn.
30 gm.
|
Post Kachnal
*Bauhinia variegata* Linn.
10 gm.
|
Gul-e-Surkh
*Rosa damascena* Mill.
30 gm.
|
Neelkanthi
*Ajuga bracteosa* Wall. ex Benth.
30 gm.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 240
- The following criteria will be strictly followed for inclusion of cases in an observational study.
- 1.Patients of either sex in the age group of 15 to 60 years.
- 2.Occurrence of the following (5-15 in number): i.Vesicles (a vesicle is a small blister, as on the skin.
- Vesicles are less than 0.5 centimeters in diameter) ii.Papules (Small solid rounded bumps rising from the skin that are each usually less than 1 centimeter in diameter (less than 3/8 inch across) iii.Pustules (Small solid rounded bumps rising from the skin that are each usually less than 1 centimeter in diameter (less than 3/8 inch across) iv.Macules (Flat , distinct, colored area of the skin less than 1 cm in diameter).
The patients of Busoor-e-Jild (Skin Eruptions) with following conditions will be excluded from the study: 1.Age <15 years and >60 years 2.Pregnancy and Lactation 3.Patients with disorders requiring long term treatment 4.Patients with more than 15 skin eruptions 5.Size of skin eruption more than 1cm 6.Eruptions due to viral diseases (Chicken pox, Measles, Herpes) 7.Patients with other inflammatory skin conditions like localized abscess/ carbuncles/ boils.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms of Busoor-e-Jild (Skin Eruptions) Two weeks
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessment Investigations will be done at baseline and end of treatment
Trial Locations
- Locations (1)
Regional Research Institute of Unani Medicine (RRIUM)
🇮🇳Bhadrak, ORISSA, India
Regional Research Institute of Unani Medicine (RRIUM)🇮🇳Bhadrak, ORISSA, IndiaDr Akhter Hussain JamaliPrincipal investigator8811907160crukxj522@gmail.comDr Rahat RazaPrincipal investigator9911315309rridelhi@gmail.comDr Syed Abdullah HussainiPrincipal investigator06784251289rriumbdk_unani@yahoo.co.in